Emmanuel Vial

USPTO Granted Patents = 14 (Patent Applications = 7)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 21)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 58(Granted Patents)

Location History:

Nimes, FR (2012 - 2018)
Paris, FR (2014 - 2018)
Nice, FR (2018 - 2022)

Company Filing History:

Etex Building Performance International Sas

Years Active: 2012-2022

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11234959 - Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema (2022-02-01),

2. 10434109 - Compositions for treating neurological disorders (2019-10-08),

3. 10398720 - Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis (2019-09-03),

4. 10119268 - Protective structure for board partitions (2018-11-06),

5. 9931326 - Composition comprising torasemide and baclofen for treating neurological disorders (2018-04-03),

6. 9867837 - Compositions for treating neurological disorders (2018-01-16),

7. 9834924 - Seismic damage reducing system for partitions (2017-12-05),

8. 9820978 - Treatment of cerebral ischemia (2017-11-21),

9. 9636316 - Baclofen and acamprosate based therapy of neurological disorders (2017-05-02),

10. 9144558 - Baclofen and acamprosate based therapy of neurological disorders (2015-09-29),

11. 8865769 - Baclofen and acamprosate based therapy of neurological disorders (2014-10-21),

12. 8741886 - Baclofen and acamprosate based therapy of neurological disorders (2014-06-03),

13. 8372240 - Production line for hydraulic binder-based, tapered-edge boards (2013-02-12),

14. 8257525 - Production method for hydraulic binder-based, tapered-edge boards (2012-09-04),

Title: Emmanuel Vial: Innovator in Pharmaceutical Compositions

Introduction

Emmanuel Vial is a prominent inventor based in Paris, France, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Vial has focused on developing innovative solutions for various medical conditions.

Latest Patents

Among his latest patents, Vial has developed compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema. This invention relates to a pharmaceutical composition that includes a compound of the avermectin family, preferably ivermectin, in a pharmaceutically acceptable carrier. It aims to provide effective treatment and prevention for individuals suffering from hand eczema. Additionally, Vial has created compositions for treating neurological disorders. This invention addresses neurological disorders related to glutamate excitotoxicity and Amyloid β toxicity. It specifically focuses on novel combinatorial therapies for conditions such as Multiple Sclerosis, Alzheimer's disease, Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, and spinal cord injury.

Career Highlights

Throughout his career, Emmanuel Vial has worked with notable companies, including Pharnext and Etex Building Performance International Sas. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Vial has collaborated with esteemed colleagues, including Daniel Cohen and Ilya Chumakov. These partnerships have further enriched his research and innovation efforts in the pharmaceutical field.

Conclusion

Emmanuel Vial's work exemplifies the spirit of innovation in pharmaceuticals, particularly in addressing complex medical conditions. His contributions through patents and collaborations continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.